AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Capstone Holding Corp. Director's Dealing 2016

Dec 19, 2016

35323_dirs_2016-12-19_6f2e9098-489d-4688-b11b-d406e9856da7.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Capstone Therapeutics Corp. (CAPS)
CIK: 0000887151
Period of Report: 2016-12-16

Reporting Person: MILLER LLOYD I III (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-12-16	Common Stock	S	38967	$0.04	Disposed	0	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	472792	Indirect
Common Stock	90344	Indirect
Common Stock	641218	Indirect
Common Stock	724100	Indirect
Common Stock	5828968	Indirect

Footnotes

F1: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. This filing shall not be deemed an admission that the reporting person is, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the beneficial owner of any equity securities covered by this filing.